Pfizer’s market cap increases by 5% within 3 months of FDA commissioner confirmation

Pfizer, one of the largest pharma firms, benefits from predictable FDA policies, leading to investor confidence and share price appreciation. Regulatory stability typically boosts large-cap pharma valuations by 3-7% in similar scenarios.

Implied probability (Yes)

55%